Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Sage Therapeutics, Inc. | 85,041 | reported | 05 Aug 2024 | tx 104+414,911−171,200 |
| Cyberkinetics Neurotechnology Systems, Inc. | 30,000 | reported | 08 Mar 2006 | tx 1−30,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Aug 2024 | TAX_WITHHOLDING | Sage Therapeutics, Inc. | 3,636 | 8.96 USD | |
| 05 Aug 2024 | GRANT_AWARD | Sage Therapeutics, Inc. | 13,500 | 0.00 USD | |
| 13 Feb 2024 | GRANT_AWARD | Sage Therapeutics, Inc. | 11,250 | 0.00 USD | |
| 13 Feb 2024 | GRANT_AWARD | Sage Therapeutics, Inc. | 22,500 | 0.00 USD | deriv |
| 02 Jan 2024 | EXERCISE | Sage Therapeutics, Inc. | 1,642 | 1.36 USD | |
| 02 Jan 2024 | EXERCISE | Sage Therapeutics, Inc. | 1,642 | 0.00 USD | deriv |
| 28 Nov 2023 | GRANT_AWARD | Sage Therapeutics, Inc. | 3,500 | 0.00 USD | |
| 28 Nov 2023 | TAX_WITHHOLDING | Sage Therapeutics, Inc. | 943 | 19.27 USD | |
| 15 Mar 2023 | EXERCISE | Sage Therapeutics, Inc. | 3,000 | 1.36 USD | |
| 15 Mar 2023 | EXERCISE | Sage Therapeutics, Inc. | 3,000 | 0.00 USD | deriv |
| 23 Feb 2023 | EXERCISE | Sage Therapeutics, Inc. | 250 | 1.36 USD | |
| 21 Feb 2023 | EXERCISE | Sage Therapeutics, Inc. | 750 | 1.36 USD | |
| 23 Feb 2023 | EXERCISE | Sage Therapeutics, Inc. | 250 | 0.00 USD | deriv |
| 21 Feb 2023 | EXERCISE | Sage Therapeutics, Inc. | 750 | 0.00 USD | deriv |
| 13 Feb 2023 | GRANT_AWARD | Sage Therapeutics, Inc. | 16,720 | 0.00 USD | deriv |
| 03 Feb 2023 | GRANT_AWARD | Sage Therapeutics, Inc. | 2,850 | 0.00 USD | |
| 03 Feb 2023 | TAX_WITHHOLDING | Sage Therapeutics, Inc. | 914 | 44.16 USD | |
| 09 Jan 2023 | EXERCISE | Sage Therapeutics, Inc. | 1,600 | 1.36 USD | |
| 09 Jan 2023 | EXERCISE | Sage Therapeutics, Inc. | 1,600 | 0.00 USD | deriv |
| 04 Jan 2023 | EXERCISE | Sage Therapeutics, Inc. | 1,800 | 1.36 USD | |
| 04 Jan 2023 | EXERCISE | Sage Therapeutics, Inc. | 1,800 | 0.00 USD | deriv |
| 17 Feb 2022 | EXERCISE | Sage Therapeutics, Inc. | 4,500 | 1.36 USD | |
| 17 Feb 2022 | EXERCISE | Sage Therapeutics, Inc. | 4,500 | 0.00 USD | deriv |
| 11 Feb 2022 | GRANT_AWARD | Sage Therapeutics, Inc. | 15,200 | 0.00 USD | deriv |
| 22 Nov 2021 | EXERCISE | Sage Therapeutics, Inc. | 2,500 | 1.36 USD |
1 purchase reported after at least 12 months of silence — most recent on 31 Dec 2015.